These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10919140)

  • 1. [Neuroanatomy of Parkinson disease. Changes in the neuronal cytoskeleton of a few disease-susceptible types of neurons lead to progressive destruction of circumscribed areas in the limbic and motor systems].
    Braak H; Rüb U; Braak E
    Nervenarzt; 2000 Jun; 71(6):459-69. PubMed ID: 10919140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathoanatomy of Parkinson's disease.
    Braak H; Braak E
    J Neurol; 2000 Apr; 247 Suppl 2():II3-10. PubMed ID: 10991663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postmortal diagnosis of Parkinson's disease].
    Sandmann-Keil D; Braak H
    Pathologe; 2005 May; 26(3):214-20. PubMed ID: 15538572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology of sporadic Parkinson's disease].
    Braak H; Del Tredici K
    Fortschr Neurol Psychiatr; 2010 Mar; 78 Suppl 1():S2-4. PubMed ID: 20195936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nigral and extranigral pathology in Parkinson's disease.
    Braak H; Braak E; Yilmazer D; Schultz C; de Vos RA; Jansen EN
    J Neural Transm Suppl; 1995; 46():15-31. PubMed ID: 8821039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).
    Braak H; Del Tredici K; Bratzke H; Hamm-Clement J; Sandmann-Keil D; Rüb U
    J Neurol; 2002 Oct; 249 Suppl 3():III/1-5. PubMed ID: 12528692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of brain destruction in Parkinson's and Alzheimer's diseases.
    Braak H; Braak E; Yilmazer D; de Vos RA; Jansen EN; Bohl J
    J Neural Transm (Vienna); 1996; 103(4):455-90. PubMed ID: 9617789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cognitive function and blood pressure regulation in Lewy body diseases].
    Asahina M
    Rinsho Shinkeigaku; 2013; 53(11):1386-8. PubMed ID: 24291999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease.
    Halliday GM; Macdonald V; Henderson JM
    Brain; 2005 Oct; 128(Pt 10):2272-80. PubMed ID: 16014651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study.
    Patt S; Gertz HJ; Gerhard L; Cervós-Navarro J
    Histol Histopathol; 1991 Jul; 6(3):373-80. PubMed ID: 1725760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system.
    Braak H; Rüb U; Sandmann-Keil D; Gai WP; de Vos RA; Jansen Steur EN; Arai K; Braak E
    Acta Neuropathol; 2000 May; 99(5):489-95. PubMed ID: 10805091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stages in the development of Parkinson's disease-related pathology.
    Braak H; Ghebremedhin E; Rüb U; Bratzke H; Del Tredici K
    Cell Tissue Res; 2004 Oct; 318(1):121-34. PubMed ID: 15338272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.
    Jellinger KA
    Mov Disord; 2012 Jan; 27(1):8-30. PubMed ID: 22081500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: four cases.
    Del Tredici K; Duda JE
    J Neurol Sci; 2011 Nov; 310(1-2):100-6. PubMed ID: 21689832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal patterns of microtubule-associated protein-2 (MAP-2) immunolabeling in neuronal nuclei and Lewy bodies in Parkinson's disease substantia nigra brain tissues.
    D'Andrea MR; Ilyin S; Plata-Salaman CR
    Neurosci Lett; 2001 Jun; 306(3):137-40. PubMed ID: 11406314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?
    Jellinger KA
    J Neural Transm Suppl; 1999; 56():1-29. PubMed ID: 10370901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
    Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
    Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggresome-related biogenesis of Lewy bodies.
    McNaught KS; Shashidharan P; Perl DP; Jenner P; Olanow CW
    Eur J Neurosci; 2002 Dec; 16(11):2136-48. PubMed ID: 12473081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.